| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |